Introduction
Irregular sleep-wake behavior is common to a vast amount of people in industrialized nations. Many are working in shift schedules, other are travelling on long distant flights. Vigilance expert systems might be helpful managing sleepwake behavior to become more regular. Mobile devices are needed to support adaptation of the expert system to individual characteristics. Data acquisition should be inexpensive, sufficiently accurate, less irritating and without specific measurement effort.
Methods
A portable system is described that records accelerations at wrist. The system is based on the development system eZ430-Chronos from Texas Instruments and is shaped as wristwatch. In addition, ambient temperature and altitude are measured. Due to limited hardware resources much effort was invested to gain recording time up to four weeks. 12 subjects have carried BioWatch for 14days. The number of handwrist accelerations were stored every 2min. From these signals waking, rest and sleep phases can be derived as well as the quality of sleep. A smartphone was utilized to assess subjective self-ratings of sleepiness every 20min.
Results
Spectral analysis of the actogram revealed duration and zero phase angle of sleep-wake cycle. Furthermore, sleep onset and wakeup time was estimated automatically from actogram and validated against visual inspection (mean deviation below 5min). Despite to the large polling interval of subjective self-assessments the mean deviation to the automatically estimated values from actogram was below 22min.
Conclusion
Vigilance expert systems have been considered as one technological revolution of the 21 st century. One still unresolved question is how to adapt them to individual sleep-wake behavior based on real data. Actigraphy could be a simple and low-cost option to provide useful data. Currently, it seems that further data, e.g. body core temperature, are needed to provide individual adaptation. Currently, BioWatch is used successfully in for supervision purposes in Fatigue Risk Management of companies in South Africa, Australia and US.
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